Ranbaxy Launches Acne Treatment Capsules in US

New Delhi: Drug firm Ranbaxy Laboratories on Wednesday launched a capsule used for treatment of severe acne in the US. Ranbaxy Laboratories Inc, a subsidiary of the company, has announced the launch of Absorica capsules in the strengths of 25 mg and 35 mg in the US market. "The product is licensed to Ranbaxy from Cipher Pharmaceuticals Inc," Ranbaxy Laboratories said in a statement. "Since isotretinoin dosing is weight-bas...